Abstract
In response to infection and/or tissue injury, cells of the host innate immune system rapidly produce a variety of structurally distinct mediators (we elect to call alarmins) that not only function as potent effectors of innate defense but also act to alarm the immune system by promoting the recruitment and activation of host leukocytes through interaction with distinct receptors. Alarmins are capable of activating antigen-presenting cells (APCs) and enhancing the development of antigen-specific immune responses. Here, we discuss the characteristics of several alarmins, a variety of potential alarmin candidates and potential implications of alarmins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bals, R. and Wilson, J.M. (2003) Cathelicidins-a family of multifunctional antimicrobial peptides. Cell Mol. Life Sci. 60, 711–720.
Bianchi, M.E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1–5.
Biragyn, A., Ruffini, P.A., Coscia, M., Harvey, L.K., Neelapu, S.S., Baskar, S., Wang, J.M. and Kwak, L.W. (2004) Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo. Blood 104, 1961–1969.
Biragyn, A., Ruffini, P.A., Leifer, C.A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A.K., Farber, J.M., Segal, D.M., Oppenheim, J.J. and Kwak, L.W. (2002) Toll-like receptor 4-dependent activation of dendritic cells by β -defensin 2. Science 298, 1025–1029.
Biragyn, A., Surenhu, M., Yang, D., Ruffini, P.A., Haines, B.A., Klyushnenkova, E., Oppenheim, J.J. and Kwak, L.W. (2001) Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J. Immunol. 167, 6644–6653.
Buck, C.B., Day, P.M., Thompson, C.D., Lubkowski, J., Lu, W., Lowy, D.R. and Schiller, J.T. (2006) Human alpha-defensins block papillomavirus infection. Proc. Natl. Acad. Sci. U.S.A. 103, 1516–21.
Chertov, O., Michiel, D.F., Xu, L., Wang, J.M., Tani, K., Murphy, W.J., Longo, D.L., Taub, D.D. and Oppenheim, J.J. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271, 2935–2940.
Deng, A., Chen, S., Li, Q., Lyu, S.C., Clayberger, C. and Krensky, A.M. (2005) Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J. Immunol. 174, 5243–8.
Garcia, J.R., Jaumann, F., Schulz, S., Krause, A., Rodriguez-Jimenez, J., Forssmann, U., Adermann, K., E, E.K., Vogelmeier, C., Becker, D., Hedrich, R., Forssmann, W.G. and Bals, R. (2001a) Identification of a novel, multifunctional β -defensin (human β -defensin 3) with specific antimicrobial activity: its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 306, 257–264.
Garcia, J.R., Krause, A., Schulz, S., Rodriguez-Jimenez, F.J., Kluver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R. and Forssmann, W.G. (2001b) Human β -defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J. 15, 1819–1821.
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J.X., Nagashima, M., Lundh, E.R., Vijay, S., Nitecki, D. Morser, J., Stern, D. and Schmidt, A.M. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752–25761.
Idzko, M., Dichmann, S., Ferrari, D., Di Virgilio, F., la Sala, A., Girolomoni, G., Panther, E. and Norgauer, J. (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100, 925–32.
Klotman, M.E. and Chang, T.L. (2006) Defensins in innate antiviral immunity. Nat. Rev. Immunol. 6, 447–456.
Kokkola, R., Andersson, A., Mullins, G., Ostberg, T., Treutiger, C.J., Arnold, B., Nawroth, P., Andersson, U., Harris, R.A. and Harris, H.E. (2005) RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 61, 1–9.
Kornbluth, R.S. and Stone, G.W. (2006) Immunostimulatory combinations: designing the next generation of vaccine adjuvants. J. Leukoc. Biol. 80, 1084–102.
Kurosaka, K., Chen, Q., Yarovinsky, F., Oppenheim, J.J. and Yang, D. (2005) Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174, 6257–6265.
Lillard Jr., J.W., Boyaka, P.N., Chertov, O., Oppenheim, J.J. and McGhee, J.R. (1999) Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. U.S.A. 96, 651–656.
Ma, X.T., Xu, B., An, L.L., Dong, C.Y., Lin, Y.M., Shi, Y. and Wu, K.F. (2006) Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses. Cancer Res. 66, 1169–1176.
Manjili, M.H., Wang, X.Y., MacDonald, I.J., Arnouk, H., Yang, G.Y., Pritchard, M.T. and Subjeck, J.R. (2004) Cancer immunotherapy and heat-shock proteins: promises and challenges. Expert Opin. Biol. Ther. 4, 363–373.
Marsland, B.J., Battig, P., Bauer, M., Ruedl, C., Lassing, U., Beerli, R.R., Dietmeier, K., Ivanova, L., Pfister, T., Vogt, L., Nakano, H., Nembrini, C., Saudan, P., Kopf, M. and Bachmann, M.F. (2005) CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22, 493–505.
Molon, B., Gri, G., Bettella, M., Gomez-Mouton, C., Lanzavecchia, A., Martinez, A.C., Manes, S. and Viola, A. (2005) T cell costimulation by chemokine receptors. Nat. Immunol. 6, 465–471.
Moser, C., Weiner, D.J., Lysenko, E., Bals, R., Weiser, J.N. and Wilson, J.M. (2002) β -Defensin 1 contributes to pulmonary innate immunity in mice. Infect. Immun. 70, 3068–3072.
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., Pestonjamasp, V., Piraino, J., Huttner, K. and Gallo, R.L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454–457.
Oppenheim, J.J. and Yang, D. (2005) Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359–365.
Park, J.S., Gamboni-Robertson, F., He, Q., Svetkauskaite, D., Kim, J.Y., Strassheim, D., Sohn, J.W., Yamada, S., Maruyama, I., Banerjee, A., Ishizaka, A. and Abraham, E. (2006) High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell. Physiol. 290, C917–C924.
Rosenberger, C.M., Gallo, R.L. and Finlay, B.B. (2004) Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. U.S.A. 101, 2422–2427.
Rouhiainen, A., Kuja-Panula, J., Wilkman, E., Pakkanen, J., Stenfors, J., Tuominen, R.K., Lepantalo, M., Carpen, O., Parkkinen, J. and Rauvala, H. (2004) Regulation of monocyte migration by amphoterin (HMGB1). Blood 104, 1174–1182.
Rovere-Querini, P., Capobianco, A., Scaffidi, P., Valentinis, B., Catalanotti, F., Giazzon, M., Dumitriu, I.E., Muller, S., Iannacone, M., Traversari, C., Bianchi, M.E. and Manfredi, A.A. (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5, 825–830.
Rugeles, M.T., Trubey, C.M., Bedoya, V.I., Pinto, L.A., Oppenheim, J.J., Rybak, S.M. and Shearer, G.M. (2003) Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS 17, 481–486.
Shi, Y., Evans, J.E. and Rock, K.L. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516–521.
Uesugi, H., Ozaki, S., Sobajima, J., Osakada, F., Shirakawa, H., Yoshida, M. and Nakao, K. (1998) Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases. J. Rheumatol. 25, 703–709.
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K.R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P.E., Abumrad, N.N., Sama, A. and Tracey, K.J. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248–251.
Wehkamp, J. and Stange, E.F. (2006) A new look at Crohn’s disease: breakdown of the mucosal antibacterial defense. Ann. N. Y. Acad. Sci. 1072, 321–331.
Wu, Z., Hoover, D.M., Yang, D., Boulegue, C., Santamaria, F., Oppenheim, J.J., Lubkowski, J. and Lu, W. (2003) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β -defensin 3. Proc. Natl. Acad. Sci. U.S.A. 100, 8880–8885.
Yang, D., Biragyn, A., Hoover, D.M., Lubkowski, J. and Oppenheim, J.J. (2004a) Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22, 181–315.
Yang, D., Chen, Q., Rosenberg, H.F., Rybak, S.M., Newton, D.L., Wang, Z.Y., Fu, Q., Tchernev, V.T., Wang, M., Schweitzer, B., Kingsmore, S.F., Patel, D.D., Oppenheim, J.J. and Howard, O.M. (2004b) Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. J. Immunol. 173, 6134–6142.
Yang, D., Chen, Q., Chertov, O. and Oppenheim, J.J. (2000) Human neutrophil defensins selectively chemoattract naïve T and immature dendritic cells. J. Leukoc. Biol. 68, 9–14.
Yang, D., Chen, Q., Schmidt, A.P., Anderson, G.M., Wang, J.M., Wooters, J., Oppenheim, J.J. and Chertov, O. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069–1074.
Yang, D., Chen, Q., Su, S.B., Zhang, P., Kurosaka, K., Caspi, R.R., Michalek, S.M., Rosenberg, H.F. and Oppenheim, J.J. (submitted) Eosinophil-derived neurotoxin acts as an alarmin to enhance Th2 immune responses by activating TLR2-MyD88 signal pathway in dendritic cells. (submitted).
Yang, D., Chen, Q., Yang, H., Tracey, K.J., Bustin, M. and Oppenheim, J.J. (2007b) High mobility group box-1 (HMGB1) protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81, 59–66.
Yang, D., Rosenberg, H.F., Chen, Q., Dyer, K.D., Kurosaka, K. and Oppenheim, J.J. (2003) Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102, 3396–3403.
Zedler, S. and Faist, E. (2006) The impact of endogenous triggers on trauma-associated inflammation. Curr. Opin. Crit. Care 12, 595–601.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this paper
Cite this paper
Oppenheim, J.J., Tewary, P., de la Rosa, G., Yang, D. (2007). Alarmins Initiate Host Defense. In: Shurin, M.R., Smolkin, Y.S. (eds) Immune-Mediated Diseases. Advances in Experimental Medicine and Biology, vol 601. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72005-0_19
Download citation
DOI: https://doi.org/10.1007/978-0-387-72005-0_19
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72004-3
Online ISBN: 978-0-387-72005-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)